论文部分内容阅读
目的探讨舒利迭联合乌灵胶囊治疗慢性阻塞性肺病(COPD)合并焦虑的临床应用价值。方法将我院于2013年1月至2015年7月期间救治的166例COPD合并抑郁患者随机分成研究组和对照组,对照组予以舒利迭治疗,研究组予以舒利迭联合乌灵胶囊治疗。治疗完毕后,对比两组患者的肺功能、焦虑情绪及不良反应。结果治疗后,研究组患者的肺功能显著优于对照组(P<0.01),汉密顿焦虑量表(HAMA)评分明显低于对照组(P<0.01),两组之间的不良反应发生率无统计学差异(P>0.05)。结论舒利迭联合乌灵胶囊治疗COPD合并焦虑的临床效果上佳,安全性良好,对于提高患者生活质量具有重要意义。
Objective To investigate the clinical value of seretide combined with wuling capsule in the treatment of chronic obstructive pulmonary disease (COPD) with anxiety. Methods A total of 166 COPD patients with depression who were treated in our hospital from January 2013 to July 2015 were randomly divided into study group and control group, control group was treated with seretide, and study group was treated with seretide combined with wuling capsule . After treatment, lung function, anxiety and adverse reactions were compared between the two groups. Results After treatment, the lung function of the study group was significantly better than that of the control group (P <0.01), and the HAMA score was significantly lower than that of the control group (P <0.01). Adverse reactions occurred between the two groups There was no statistical difference (P> 0.05). Conclusion Seretide combined with Wuling capsule in the treatment of COPD with anxiety has good clinical effect and good safety, which is of great significance for improving the quality of life of patients.